Effectiveness of complement inhibitors against refractory antibody-mediated rejection of lung transplantation: Two clinical cases
Transplant Immunology · 2025
DOI: 10.1016/j.trim.2025.102174 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transplant Immunology, 2025. Verfasst von Hadrien Mallet und 8 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Grenoble Alpes, Pharmacy Department, Grenoble Alpes University Hospital, Grenoble, France. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Complement Inactivating Agents, Graft Rejection, Lung Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Antibody-mediated rejection (AMR) has been recognized as a significant cause of acute and chronic lung allograft dysfunction after lung transplantation. Some treatments, eculizumab, an anti-complement (C)5 component monoclonal antibody (Mab), seem to have a promising effect in the management of some patients with AMR. We present two patients with acute AMR after lung transplantation who received the anti-C5 Mab therapy. In both cases, we identified the presence of C4d deposition in the peritubular capillaries on trans-alveolar biopsies, which suggested activation of complement in AMR. Prior to eculizumab therapy, both patients had also received immunoadsorption, courses of intravenous immunoglobulins (IVIG) and rituximab. For the first patient, we have shown that eculizumab can serve as an effective bridge to re-transplantation. For the second patient, we observed the absence of clinical and biological efficacy, and without a clear therapeutic efficacy the therapy with eculizumab had been discontinued after two months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Univ. Grenoble Alpes, Pharmacy Department, Grenoble Alpes University Hospital, Grenoble, France.
- Univ. Grenoble Alpes, Pneumology and Physiology Department, Grenoble Alpes University Hospital, Grenoble, France.
- Univ. Grenoble Alpes, INSERM U1055, Pharmacy Department, Grenoble Alpes University Hospital, LBFA, Grenoble, France. Electronic address: qperrier@chu-grenoble.fr.
- Univ. Grenoble Alpes, Nephrology, Hemodialysis, Apheresis and Kidney Transplant Department, Grenoble Alpes University Hospital, Grenoble, France.
- Univ. Grenoble Alpes, INSERM, Pneumology and Physiology department, HP2 laboratory U1300, Grenoble Alpes University Hospital, Grenoble, France.
- Univ. Grenoble Alpes, CNRS, Pharmacy Department, TIMC, UMR5525, Grenoble Alpes University, Grenoble, France.
Zitieren
APA
Mallet, H., Razat, L., Perrier, Q., Briault, A., Raymond, C. S., Falque, L., Rostaing, L., Degano, B., & Bedouch, P. (2025). Effectiveness of complement inhibitors against refractory antibody-mediated rejection of lung transplantation: Two clinical cases. Transplant Immunology. https://doi.org/10.1016/j.trim.2025.102174
Vancouver
Mallet H, Razat L, Perrier Q, Briault A, Raymond CS, Falque L, et al. Effectiveness of complement inhibitors against refractory antibody-mediated rejection of lung transplantation: Two clinical cases. Transplant Immunology. 2025. doi:10.1016/j.trim.2025.102174
BibTeX
@article{Mallet2025,
author = {Mallet, Hadrien and Razat, Laurent and Perrier, Quentin and Briault, Amandine and Raymond, Christel Saint and Falque, Loic and Rostaing, Lionel and Degano, Bruno and Bedouch, Pierrick},
title = {Effectiveness of complement inhibitors against refractory antibody-mediated rejection of lung transplantation: Two clinical cases},
journal = {Transplant Immunology},
year = {2025},
doi = {10.1016/j.trim.2025.102174}
}
EUVIMED